Drug
Men2312
Men2312: highest development phase Phase 1, developed by Stemline Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Stemline Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| MEN2312 NCT06638307 | Phase 1 | Advanced Breast Cancer |
Latest
No recent events.
Follow Men2312 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.